Product Description
COVID-19 Diagnostics Demand Outlook: Market Forecasts by Technology, Product, Channel and Country - Market Size Outlook with Executive and Consultant Guides 2023 to 2027
Publication date: September 2023
Page count: 426
The pandemic may have ended but COVID-19 is here to stay.
This is still a dynamic market as multiple competitors are vying for the highly lucrative future of respiratory diagnostics.
New variants and the situation in China have changed the pandemic outlook, and we have changed ours. Get the revised outlook based on the latest data. A new dynamic market is emerging for COVID-19 based diagnostics; testing is moving into physicians’ offices and even into the home. Saliva tests? Handheld multiplex testers? Home based testing sticks? What about the Workplace market where safety is paramount? What happens to the large laboratory capacity that was built up to handle a pandemic now in decline? Learn all about these changing markets in our latest report.
Our latest outlook discusses the opportunities and challenges facing the diagnostics organizations; breaking out market size and segment growth rates to 2027 by the following:
- Technology
- PCR, Multiplex PCR, Sequencing, Antibody, Antigen
- Product
- Instruments, Reagents and Kits, Extraction, Collection
- Channel
- Public, Hospital, Clinic, Workplace, DTC / OTC, Wastewater
- Country
- USA, Canada, Germany, France, UK, RoEUR, Japan, China, S. Korea, RoAP, Brazil, Mexico, RoLA, ME&A, Global
Learn all about this changing market and get on top of the situation quickly with our Market Guides and Situation Analysis. Make confident projections using the latest data.
Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready by phone or email to help you use it.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
- B.Sc. (Chemistry) University of BC
- M.B.A. (Finance and Policy) University of BC
- Market Research Seminar - Burke Institute
- Finance for Senior Executives - Harvard Business School
